Laguno, M <br/><br/>
Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.  [electronic resource] 

 -  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases  Dec 2016 
 - 46-51 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1878-3511 
<br/><br/><label>Standard No.: </label>10.1016/j.ijid.2016.10.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Coinfection<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>HIV Infections--complications<br/>Hepacivirus--drug effects<br/>Hepatitis C--complications<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--therapeutic use<br/>Proline--analogs & derivatives<br/>Prospective Studies<br/>Recombinant Proteins--therapeutic use<br/>Retreatment<br/>Ribavirin--therapeutic use<br/>Spain<br/>Treatment Outcome<br/>Viral Nonstructural Proteins--antagonists & inhibitors